Product Images Fluticasone Propionate Hfa
View Photos of Packaging, Labels & Appearance
- Fluticasone propionate chemical structure - fluticasonepropionatehfa spl graphic 01
- Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - fluticasonepropionatehfa spl graphic 02
- Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - fluticasonepropionatehfa spl graphic 03
- Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - fluticasonepropionatehfa spl graphic 04
- Figure A - fluticasonepropionatehfa spl graphic 05
- Figure B - fluticasonepropionatehfa spl graphic 06
- Figure C - fluticasonepropionatehfa spl graphic 07
- Figure D - fluticasonepropionatehfa spl graphic 08
- Figure E - fluticasonepropionatehfa spl graphic 09
- Figure F - fluticasonepropionatehfa spl graphic 10
- Figure G - fluticasonepropionatehfa spl graphic 11
- Figure H - fluticasonepropionatehfa spl graphic 12
- Figure I - fluticasonepropionatehfa spl graphic 13
- Figure J - fluticasonepropionatehfa spl graphic 14
- Fluticasone Propionate HFA Inh Aerosol 44mcg - fluticasonepropionatehfa spl graphic 15
Product Label Images
The following 15 images provide visual information about the product associated with Fluticasone Propionate Hfa NDC 68788-8762 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Fluticasone propionate chemical structure - fluticasonepropionatehfa spl graphic 01
Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - fluticasonepropionatehfa spl graphic 02
This is not a readable text.*
Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - fluticasonepropionatehfa spl graphic 03
This text provides information on the change from baseline in forced expiratory volume (FEV) for different doses of fluticasone propionate HFA compared to a placebo over a 12-week period. The doses of fluticasone propionate HFA mentioned are 83 mcg twice daily, 220 mcg twice daily, and 440 mcg twice daily.*
Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - fluticasonepropionatehfa spl graphic 04
This text mentions the percentage of subjects at various dose levels of Fluticasone Propionate HFA (440 mcg twice daily and 880 mcg twice daily) and the percentage of subjects with an increase in dose. The data suggests a reduction in dose by 100% for some subjects.*
Figure A - fluticasonepropionatehfa spl graphic 05
This product seems to be a metal canister with a dark orange plastic actuator and mouthpiece, topped with a peach cap. The dark orange color scheme adds a stylish touch to the design.*
Figure B - fluticasonepropionatehfa spl graphic 06
Figure C - fluticasonepropionatehfa spl graphic 07
Figure D - fluticasonepropionatehfa spl graphic 08
Figure E - fluticasonepropionatehfa spl graphic 09
This may be a description related to a smoking device or accessory. The item seems to have a mouthpiece with the capability of being placed in a downward position. The color mentioned is dark orange.*
Figure F - fluticasonepropionatehfa spl graphic 10
This text describes the action of exhaling or breathing out as much air as possible. It is a simple and clear instruction related to breathing exercises or techniques.*
Figure G - fluticasonepropionatehfa spl graphic 11
Figure H - fluticasonepropionatehfa spl graphic 12
Figure I - fluticasonepropionatehfa spl graphic 13
Figure J - fluticasonepropionatehfa spl graphic 14
Fluticasone Propionate HFA Inh Aerosol 44mcg - fluticasonepropionatehfa spl graphic 15
This text contains information about a medication called Fluticasone Propionate HFA Inhaler Aerosol 44mcg, which is a generic version of Flovent HFA. Each actuation of the inhaler delivers 50mcg of fluticasone propionate from the valve and 44mcg from the actuator. The medication is manufactured by Prasco Laboratories. The text also includes storage instructions, directions for use, a caution regarding federal law on drug transfer, and information in both English and Spanish. The text lacks specific details on indications or side effects of the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
